Cargando…
Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transf...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166747/ https://www.ncbi.nlm.nih.gov/pubmed/30310283 http://dx.doi.org/10.2147/IJN.S166901 |
_version_ | 1783360088990285824 |
---|---|
author | Zariwala, M Gulrez Bendre, Harshada Markiv, Anatoliy Farnaud, Sebastien Renshaw, Derek Taylor, Kevin MG Somavarapu, Satyanarayana |
author_facet | Zariwala, M Gulrez Bendre, Harshada Markiv, Anatoliy Farnaud, Sebastien Renshaw, Derek Taylor, Kevin MG Somavarapu, Satyanarayana |
author_sort | Zariwala, M Gulrez |
collection | PubMed |
description | BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transform infra-red (FT-IR) spectroscopy and proton NMR spectroscopy (H-NMR). Liposomes encapsulating ferrous sulphate as a model hydrophilic drug for intestinal delivery were prepared with or without OPC inclusion (Lipo-Fe and OPC-Lipo-Fe). RESULTS: Entrapment of iron was significantly higher in OPC containing liposomes compared to controls. Quantitative iron absorption from the OPC liposomes was significantly higher (1.5-fold P<0.05) than free ferrous sulphate controls. Qualitative uptake analysis by confocal imaging using coumarin-6 dye loaded liposomes also indicated higher cellular uptake and internalization of the OPC-containing liposomes. CONCLUSION: These findings suggest that addition of OPC during liposome preparation creates robust vesicles that have improved mucoadhesive and absorption enhancing properties. The chitosan derivative OPC therefore provides a novel alternative for formulation of delivery vehicles targeting intestinal absorption. |
format | Online Article Text |
id | pubmed-6166747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61667472018-10-11 Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery Zariwala, M Gulrez Bendre, Harshada Markiv, Anatoliy Farnaud, Sebastien Renshaw, Derek Taylor, Kevin MG Somavarapu, Satyanarayana Int J Nanomedicine Original Research BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transform infra-red (FT-IR) spectroscopy and proton NMR spectroscopy (H-NMR). Liposomes encapsulating ferrous sulphate as a model hydrophilic drug for intestinal delivery were prepared with or without OPC inclusion (Lipo-Fe and OPC-Lipo-Fe). RESULTS: Entrapment of iron was significantly higher in OPC containing liposomes compared to controls. Quantitative iron absorption from the OPC liposomes was significantly higher (1.5-fold P<0.05) than free ferrous sulphate controls. Qualitative uptake analysis by confocal imaging using coumarin-6 dye loaded liposomes also indicated higher cellular uptake and internalization of the OPC-containing liposomes. CONCLUSION: These findings suggest that addition of OPC during liposome preparation creates robust vesicles that have improved mucoadhesive and absorption enhancing properties. The chitosan derivative OPC therefore provides a novel alternative for formulation of delivery vehicles targeting intestinal absorption. Dove Medical Press 2018-09-27 /pmc/articles/PMC6166747/ /pubmed/30310283 http://dx.doi.org/10.2147/IJN.S166901 Text en © 2018 Zariwala et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zariwala, M Gulrez Bendre, Harshada Markiv, Anatoliy Farnaud, Sebastien Renshaw, Derek Taylor, Kevin MG Somavarapu, Satyanarayana Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title | Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title_full | Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title_fullStr | Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title_full_unstemmed | Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title_short | Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
title_sort | hydrophobically modified chitosan nanoliposomes for intestinal drug delivery |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166747/ https://www.ncbi.nlm.nih.gov/pubmed/30310283 http://dx.doi.org/10.2147/IJN.S166901 |
work_keys_str_mv | AT zariwalamgulrez hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT bendreharshada hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT markivanatoliy hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT farnaudsebastien hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT renshawderek hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT taylorkevinmg hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery AT somavarapusatyanarayana hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery |